REACH: EU industry makes strong case for exemption for devices
This article was originally published in Clinica
The EU electromedical device and diagnostic industry associations, COCIR and EDMA, have launched an eleventh-hour mission to try to persuade the European Parliament once again to exempt medical devices from the proposed chemicals legislation, REACH, on the registration, evaluation, authorisation and restriction of chemicals.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.